7. • Evidence-based, multidisciplinary, and comprehensive
intervention for patients with chronic respiratory
diseases who are symptomatic and often have
decreased daily life activities
• Integrated into the individualized treatment of the
patient, pulmonary rehabilitation is designed to reduce
symptoms, optimize functional status, increase
participation, reduce health care costs through
stabilizing or reversing systemic manifestations of the
disease, and increase activities & QOL
ATS – ERS Definition
9. Benefits of Pulmonary Rehabilitation
Pulmonary rehabilitation does not reverse nor have any direct effect
on the primary respiratory pathophysiology, yet it has proven to
improve the following:
10. Control of symptoms of cough and fatigue:
Real time eval.: MRC breathlessness & Borg dyspnea scale
Recall of symptoms
Performance evaluation: Ability to do ADL
Directly observed or self reported + PFTs, ABG or Oximetry
Exercise tolerance:
6 minutes walking test
Cardiopulmonary exercise testing
Quality of life: (specific or non-specific)
Chronic respiratory disease questionnaire & SGRQs
SF- 36
Assessment of respiratory and peripheral muscle strength
Nutritional assessment
History, Laboratory, Anthropometric, Calorimetry (D&ID)
Baseline Evaluation
11. Evaluation of Respiratory Muscle Affection
1. Confirm respiratory muscle weakness (respiratory
muscle assessment): S&S, U/S, PFT, Pimax, Pemax, EMG
2. Assess cough (PeMax < 60 cm H2O)
3. Assess need for ventilatory support (20-30-40 rule)
Degree of respiratory muscle weakness cannot be predicted
by the degree of peripheral muscle weakness.
--> tests of respiratory muscle function are essential to
identify the patient who is at risk for respiratory failure.
12.
13.
14. Need for Ventilatory Support is warranted if
measured values fall below the “20/30/40 rule” :
- VC falls below 20 mL/kg,
- MIP above −30 cm H2O, or
- MEP below 40 cm H2O.
15. Begin therapies early, when you
notice the first signs of a weakened cough.
DO NOT WAIT until the cough
is noticeably weak (or non-existent).
16. •Breathing Strategies
•Normal Lung Function and
Pathophysiology of Lung Disease
•Proper Use of Medications, including Oxygen
•Bronchial Hygiene Techniques
•Benefits of Exercise and Maintaining Physical Activities
•Energy Conservation & Work Simplification Techniques
•Eating Right
1- Education
17. • Irritant Avoidance, including Smoking Cessation
• Prevention and Early Treatment of Respiratory
Exacerbations
• Indications for Calling the Health Care Provider
• Coping with Disease and End-of-Life Planning
• Anxiety and Panic Control, including Relaxation
Techniques and Stress Management
18. Components of exercise training:
• Lower extremity exercises
• Arm exercises
• Ventilatory muscle training
Types of exercise:
• Endurance or aerobic
• Strength or resistance
2- Exercise training
20. • Walking
• Treadmill
• Stationary bicycle
• Stair climbing
• Sit & Stand
• Water based exercises
Lower extremity exercise
21. • Arm cycle ergometer
• Unsupported arm lifting
• Lifting weights
Upper extremity exercise
22. Strengthening exercises:
When strength exercise was added to standard exercise
protocol; led to:
greater increase in muscle strength and muscle mass
(FFM) increased mid-thigh circumference
23. 30 breaths twice daily
Intensity: 50% of Pimax
Increase 5% load/wk
Extent: for 8 wks
Ventilatory muscle training
32. Why intervene?
•High prevalence and association with morbidity and
mortality
•Higher caloric requirements from exercise training in
pulmonary rehabilitation, which may further aggravate
these abnormalities (without supplementation)
•Enhanced benefits, which will result from structured
exercise training.
Add?
- Thicker fluids and Good hydration
- Puréed or less solid food
For those having bulbar affection and risk of aspiration
3- Nutritional Interventions
33. Should be considered if :
•BMI less than 21 kg/m2
•Involuntary weight loss of >10% during the last 6 months
or more than 5% in the past month (can’t depend in edema)
•Depletion in FFM or lean body mass (make QoL worse and
less tolerant to exercise even when normal weight)
Nutritional Supplementation
34. INTERVENTION WEIGHT
GAIN
FFM GAIN EXERCISE
CAPACITY
CALORIC SUPP. + - -
CALORIC
SUPPLEMENTATION +
EXERCISE TRAINING
++ + +
STRENGTH EXERCISE - + -
35. • Screening for anxiety and depression should be part of
the initial assessment.
• Mild or moderate levels of anxiety or depression
related to the disease process may improve with
pulmonary rehabilitation
• Patients with significant psychiatric disease should be
referred for appropriate professional care (ATS/ERS
STATEMENT)
4- Psychological considerations
36. 5- Outcome Assessment
Providing patients with an opportunity to give
feedback about the program is a useful measure
of quality control.
Patient feedback also allows coordinators to
evaluate the components of pulmonary
rehabilitation that patients find most useful.
The questionnaire should also provide patients
with a variety of answering options
Exercise capacity measurement
37. Control of symptoms of cough and fatigue:
Real time eval.: MRC breathlessness & Borg dyspnea scale
Recall of symptoms
Performance evaluation: Ability to do ADL
Directly observed or self reported
Exercise tolerance:
6 minute walking test
Cardiopulmonary exercise testing
Quality of life:
Chronic respiratory disease questionnaire
St Georges’s respiratory questionnaire
SF- 36
Assessment of respiratory and peripheral muscle strength
Nutritional assessment
Outcome Evaluation
38. • Current guidelines does not comment on maintenance & repeat
rehabilitation
• Yearly repeat rehabilitation program had shown: Short term
benefits in the form of less frequent exacerbations
• But no long term physiological effects on exercise tolerance,
dyspnea & HRQL but in 6Ms begin loss of benefits
6- Maintenance rehabilitation &
Repeat rehabilitation program
39.
40. For people with neuromuscular disorders
who are experiencing respiratory difficulty, however,
oxygen therapy must be used with great caution.
Mechanical ventilation (preferably non-invasive)
should be the initial therapy for people with
neuromuscular disorders who experience
hypoxemia.
41. NPPV will be unsuccessful when any of the
following exist:
1.Bulbar dysfunction
2.Upper airway obstruction
3.Retention of respiratory secretions
4.Poor cooperation
5.Inadequate cough.
Mechanical Ventilation
42. Invasive MV
Should be initiated early for the following reasons:
•Intubation itself has risks that are best managed in a
controlled setting dysautonomia increases the risk of
severe hypotension and bradycardia .
•decrease the risk of early-onset pneumonia.
43. Predictors of successful Extubation
• (MIP) more negative than -50 cm H2O
• Improvement VC by > 4 mL/kg from
preintubation to preextubation.
Predictors of failed extubation
• Dysautonomia
• Advanced age
• Pulmonary complications
(pneumonia, atelectasis) were
associated with extubation failure
44. Tracheostomy
1. Difficulty clearing their secretions.
2. Intermittent long-term mechanical ventilation, but in
whom NPPV is contraindicated (e.g, severe bulbar
dysfunction).
3. Intermittent long-term NPPV is no longer sufficient.
4. Fail to wean from invasive MV
45. General Care
•Correct electrolyte abnormalities
•Avoid neuromuscular blocking agents, aminoglycosides,
and glucocorticoids.
•Nutritional status should be maintained
•Prophylaxis for DVT and stress gastric ulcers should be
provided when indicated.
•The head of the bed should be elevated by 45º to
decrease the risk for ventilator-associated pneumonia .
46. Decisions regarding long-term support
Progressive neuromuscular diseases of childhood, such
as spinal muscular atrophy and Duchenne muscular
dystrophy present different challenges, as parents are
often the main decision makers.
[long-term ventilatory support is more common and
often associated with good quality of life].
47. Other Ways of Care
- Treat respiratory infections as early as possible
- Guide against aspiration
- Prevent GERD
- Well control of co-morbid diseases
- Diaphragmatic pacing in severe weakness